Sage Journals: Discover world-class research

Retricted access

Review article

First published 2017-9

Pathogenesis,Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity

Alessandro Inno, Giulio Metro, Paolo Bironzo [...]

Tumori Journal

Retricted access

Research article

First published 2019-6

Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicities

Catherine E Renna, Elizabeth N Dow, Jason J Bergsbaken [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025-11

Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma

Nabil E. Omar, Hazem Elewa, Kareem A. El-Fass [...]

Cancer Control

Retricted access

Research article

First published 2026

Incidence of endocrine toxicities in patients with solid tumor malignancies receiving curative-intent immune checkpoint inhibitor (ICI) therapy: A single institution experience

Hana Kurz, Hang Zeng, Miranda Benfield [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities

Rossanna C. Pezo, Matthew Wong, Alberto Martin

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2021-4

Impact of pharmacist-managed immune checkpoint inhibitor toxicities

Sonny Le, Brandon Chang, Anthony Pham [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2023

A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines

Kofi N Donkor, Hyeree Jang, Reena Sail

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2021

Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review

Laure Thouvenin, Timothée Olivier, Giuseppe Banna [...]

Therapeutic Advances in Drug Safety

Retricted access

Case report

First published 2019-12

Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer

Giulia Galli, Claudia Proto, Mara Cossa [...]

Tumori Journal

Open access

Case report

First published 2022-10

Teriprizumab-induced myocarditis in a patient with cholangiocarcinoma: a case report

Yunyao Ye, Yiping Li, Sihui Zhang [...]

Journal of International Medical Research

Search results